$ALRN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AILERON THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AILERON THERAPEUTICS INC. Get notifications about new insider transactions in AILERON THERAPEUTICS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 17 2021 | ALRN | AILERON THERAPEUTI ... | Morrison Jodie Pope | Director | Option Exercise | A | 1.29 | 96,000 | 123,840 | 96,000 | |
Jun 17 2021 | ALRN | AILERON THERAPEUTI ... | Vukovic Vojo | Chief Medical Offic ... | Option Exercise | A | 1.29 | 400,000 | 516,000 | 400,000 | |
Jan 08 2021 | ALRN | AILERON THERAPEUTI ... | Satter Muneer A | See Remarks | Buy | P | 1.10 | 9,000,000 | 9,900,000 | 16,609,449 | 7.6 M to 16.6 M (+118.27 %) |
Jun 24 2020 | ALRN | AILERON THERAPEUTI ... | Wanstall Rick | See Remarks | Option Exercise | A | 1.20 | 91,000 | 109,200 | 91,000 | |
Jun 18 2020 | ALRN | AILERON THERAPEUTI ... | Sigal Nolan Howard | Director | Option Exercise | A | 1.15 | 12,500 | 14,375 | 12,500 | |
Jun 18 2020 | ALRN | AILERON THERAPEUTI ... | VON RICKENBACH JOSEF H | Director | Option Exercise | A | 1.15 | 12,500 | 14,375 | 12,500 | |
Jun 18 2020 | ALRN | AILERON THERAPEUTI ... | MCKEE WILLIAM | Director | Option Exercise | A | 1.15 | 12,500 | 14,375 | 12,500 | |
Jun 18 2020 | ALRN | AILERON THERAPEUTI ... | Morrison Jodie Pope | Director | Option Exercise | A | 1.15 | 12,500 | 14,375 | 12,500 | |
Jun 18 2020 | ALRN | AILERON THERAPEUTI ... | Bailey Jeffrey Allen | Director | Option Exercise | A | 1.15 | 12,500 | 14,375 | 12,500 | |
Jun 18 2020 | ALRN | AILERON THERAPEUTI ... | Ambros Reinhard J. | Director | Option Exercise | A | 1.15 | 12,500 | 14,375 | 12,500 | |
Jun 17 2020 | ALRN | AILERON THERAPEUTI ... | Ambros Reinhard J. | Director | Buy | P | 1.22 | 5,800 | 7,076 | 5,800 | 0 to 5.8 K |
Jun 09 2020 | ALRN | AILERON THERAPEUTI ... | VON RICKENBACH JOSEF H | Director | Buy | P | 1.10 | 227,272 | 249,999 | 445,460 | 218.2 K to 445.5 K (+104.16 %) |
Jun 09 2020 | ALRN | AILERON THERAPEUTI ... | Satter Muneer A | Director | Buy | P | 1.10 | 3,700,000 | 4,070,000 | 7,609,449 | 3.9 M to 7.6 M (+94.64 %) |
Feb 04 2020 | ALRN | AILERON THERAPEUTI ... | Annis Allen | SVP, Research | Option Exercise | A | 0.67 | 125,000 | 83,750 | 125,000 | |
Feb 04 2020 | ALRN | AILERON THERAPEUTI ... | Vukovic Vojo | SVP, Chief Medical ... | Option Exercise | A | 0.67 | 225,000 | 150,750 | 225,000 | |
Feb 04 2020 | ALRN | AILERON THERAPEUTI ... | Aivado Manuel | See Remarks | Option Exercise | A | 0.67 | 400,000 | 268,000 | 400,000 | |
Feb 04 2020 | ALRN | AILERON THERAPEUTI ... | Annis Allen | SVP, Research | Option Exercise | A | 0.67 | 125,000 | 83,750 | 125,000 | |
Feb 04 2020 | ALRN | AILERON THERAPEUTI ... | Vukovic Vojo | SVP, Chief Medical ... | Option Exercise | A | 0.67 | 225,000 | 150,750 | 225,000 | |
Feb 04 2020 | ALRN | AILERON THERAPEUTI ... | Aivado Manuel | See Remarks | Option Exercise | A | 0.67 | 400,000 | 268,000 | 400,000 | |
Nov 18 2019 | ALRN | AILERON THERAPEUTI ... | Bailey Jeffrey Allen | Director | Buy | P | 0.51 | 39,142 | 19,962 | 74,894 | 35.8 K to 74.9 K (+109.48 %) |
Nov 18 2019 | ALRN | AILERON THERAPEUTI ... | Bailey Jeffrey Allen | Director | Buy | P | 0.51 | 15,858 | 8,088 | 35,752 | 19.9 K to 35.8 K (+79.71 %) |
Nov 14 2019 | ALRN | AILERON THERAPEUTI ... | Bailey Jeffrey Allen | Director | Buy | P | 0.53 | 19,894 | 10,544 | 19,894 | 0 to 19.9 K |
Sep 16 2019 | ALRN | AILERON THERAPEUTI ... | VON RICKENBACH JOSEF H | Director | Buy | P | 0.97 | 25,000 | 24,255 | 218,188 | 193.2 K to 218.2 K (+12.94 %) |
Sep 16 2019 | ALRN | AILERON THERAPEUTI ... | VON RICKENBACH JOSEF H | Director | Buy | P | 0.98 | 88,145 | 86,250 | 193,188 | 105 K to 193.2 K (+83.91 %) |
Sep 05 2019 | ALRN | AILERON THERAPEUTI ... | VON RICKENBACH JOSEF H | Director | Buy | P | 0.71 | 23,225 | 16,583 | 105,043 | 81.8 K to 105 K (+28.39 %) |
Sep 04 2019 | ALRN | AILERON THERAPEUTI ... | VON RICKENBACH JOSEF H | Director | Buy | P | 0.70 | 13,466 | 9,428 | 81,818 | 68.4 K to 81.8 K (+19.70 %) |
Sep 04 2019 | ALRN | AILERON THERAPEUTI ... | VON RICKENBACH JOSEF H | Director | Buy | P | 0.73 | 15,000 | 10,968 | 68,352 | 53.4 K to 68.4 K (+28.12 %) |
Sep 03 2019 | ALRN | AILERON THERAPEUTI ... | VON RICKENBACH JOSEF H | Director | Buy | P | 0.77 | 3,600 | 2,771 | 53,352 | 49.8 K to 53.4 K (+7.24 %) |
Aug 20 2019 | ALRN | AILERON THERAPEUTI ... | Vukovic Vojo | SVP, Chief Medical ... | Buy | P | 0.59 | 75,000 | 44,453 | 75,000 | 0 to 75 K |
Aug 15 2019 | ALRN | AILERON THERAPEUTI ... | Gregory Kathryn | SVP, Chief Business ... | Buy | P | 0.65 | 45,000 | 29,025 | 45,000 | 0 to 45 K |
Aug 15 2019 | ALRN | AILERON THERAPEUTI ... | Gregory Kathryn | SVP, Chief Business ... | Buy | P | 0.65 | 45,000 | 29,025 | 45,000 | 0 to 45 K |
Jun 24 2019 | ALRN | AILERON THERAPEUTI ... | VON RICKENBACH JOSEF H | Director | Option Exercise | A | 0.86 | 25,000 | 21,500 | 25,000 | |
Jun 24 2019 | ALRN | AILERON THERAPEUTI ... | MCKEE WILLIAM | Director | Option Exercise | A | 0.86 | 25,000 | 21,500 | 25,000 | |
Jun 21 2019 | ALRN | AILERON THERAPEUTI ... | MCARTHUR JOHN H | Director | Option Exercise | A | 0.86 | 25,000 | 21,500 | 25,000 | |
Jun 21 2019 | ALRN | AILERON THERAPEUTI ... | Sigal Nolan Howard | Director | Option Exercise | A | 0.86 | 5,000 | 4,300 | 5,000 | |
Jun 21 2019 | ALRN | AILERON THERAPEUTI ... | Morrison Jodie Pope | Director | Option Exercise | A | 0.86 | 25,000 | 21,500 | 25,000 | |
Jun 21 2019 | ALRN | AILERON THERAPEUTI ... | Ambros Reinhard J. | Director | Option Exercise | A | 0.86 | 50,000 | 43,000 | 50,000 | |
Jun 21 2019 | ALRN | AILERON THERAPEUTI ... | Bailey Jeffrey Allen | Director | Option Exercise | A | 0.86 | 50,000 | 43,000 | 50,000 | |
Apr 17 2019 | ALRN | AILERON THERAPEUTI ... | Wanstall Rick | VP, Finance and Ope ... | Option Exercise | A | 1.75 | 59,000 | 103,250 | 59,000 | |
Apr 17 2019 | ALRN | AILERON THERAPEUTI ... | Dougherty Donald | SVP & Chief Financi ... | Option Exercise | A | 1.75 | 150,000 | 262,500 | 150,000 | |
Apr 17 2019 | ALRN | AILERON THERAPEUTI ... | Vukovic Vojo | SVP, Chief Medical ... | Option Exercise | A | 1.75 | 100,000 | 175,000 | 100,000 | |
Apr 17 2019 | ALRN | AILERON THERAPEUTI ... | Aivado Manuel | President and CEO | Option Exercise | A | 1.75 | 500,000 | 875,000 | 500,000 | |
Apr 17 2019 | ALRN | AILERON THERAPEUTI ... | Annis Allen | SVP, Research | Option Exercise | A | 1.75 | 100,000 | 175,000 | 100,000 | |
Apr 17 2019 | ALRN | AILERON THERAPEUTI ... | Gregory Kathryn | SVP, Chief Business ... | Option Exercise | A | 1.75 | 20,000 | 35,000 | 20,000 | |
Apr 03 2019 | ALRN | AILERON THERAPEUTI ... | Sigal Nolan Howard | Director | Option Exercise | A | 1.82 | 20,000 | 36,400 | 20,000 | |
Apr 02 2019 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.90 | 20,610 | 39,159 | 2,079,394 | 2.1 M to 2.1 M (-0.98 %) |
Apr 02 2019 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.85 | 106,540 | 197,099 | 2,100,004 | 2.2 M to 2.1 M (-4.83 %) |
Mar 15 2019 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.92 | 43,800 | 84,096 | 2,206,544 | 2.3 M to 2.2 M (-1.95 %) |
Mar 15 2019 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.88 | 13,800 | 25,944 | 2,250,344 | 2.3 M to 2.3 M (-0.61 %) |
Mar 15 2019 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 2.12 | 132,738 | 281,405 | 2,264,144 | 2.4 M to 2.3 M (-5.54 %) |
Feb 25 2019 | ALRN | AILERON THERAPEUTI ... | Gregory Kathryn | SVP, Chief Business ... | Option Exercise | A | 1.47 | 100,000 | 147,000 | 100,000 | |
Nov 06 2018 | ALRN | AILERON THERAPEUTI ... | Vukovic Vojo | SVP, Chief Medical ... | Option Exercise | A | 2.16 | 150,000 | 324,000 | 150,000 | |
Sep 07 2018 | ALRN | AILERON THERAPEUTI ... | Aivado Manuel | President and CEO | Option Exercise | A | 3.39 | 232,914 | 789,578 | 232,914 | |
Aug 22 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 2.30 | 20,388 | 46,892 | 2,396,882 | 2.4 M to 2.4 M (-0.84 %) |
Aug 20 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 2.10 | 8,700 | 18,270 | 2,417,270 | 2.4 M to 2.4 M (-0.36 %) |
Aug 20 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 2.10 | 8,808 | 18,497 | 2,425,970 | 2.4 M to 2.4 M (-0.36 %) |
Aug 16 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 2.15 | 2,635 | 5,665 | 2,434,778 | 2.4 M to 2.4 M (-0.11 %) |
Aug 16 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 2.26 | 3,300 | 7,458 | 2,437,413 | 2.4 M to 2.4 M (-0.14 %) |
Aug 14 2018 | ALRN | AILERON THERAPEUTI ... | LONGENECKER JOHN P PHD | President and CEO | Buy | P | 2.45 | 10,000 | 24,500 | 10,000 | 0 to 10 K |
Aug 14 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 2.36 | 1,600 | 3,776 | 2,440,713 | 2.4 M to 2.4 M (-0.07 %) |
Aug 14 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 2.44 | 5,615 | 13,701 | 2,442,313 | 2.4 M to 2.4 M (-0.23 %) |
Aug 10 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 2.48 | 235 | 583 | 2,447,928 | 2.4 M to 2.4 M (-0.01 %) |
Aug 10 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 2.78 | 1,000 | 2,780 | 2,448,163 | 2.4 M to 2.4 M (-0.04 %) |
Aug 08 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 2.97 | 1,739 | 5,165 | 2,449,163 | 2.5 M to 2.4 M (-0.07 %) |
Aug 08 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 3.02 | 2,942 | 8,885 | 2,450,902 | 2.5 M to 2.5 M (-0.12 %) |
Aug 06 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 3.33 | 4,702 | 15,658 | 2,453,844 | 2.5 M to 2.5 M (-0.19 %) |
Aug 02 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 3.22 | 8,181 | 26,343 | 2,458,546 | 2.5 M to 2.5 M (-0.33 %) |
Aug 02 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 3.07 | 4,500 | 13,815 | 2,466,727 | 2.5 M to 2.5 M (-0.18 %) |
Jul 31 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 3.27 | 2,000 | 6,540 | 2,471,227 | 2.5 M to 2.5 M (-0.08 %) |
Jul 31 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 3.38 | 6,458 | 21,828 | 2,473,227 | 2.5 M to 2.5 M (-0.26 %) |
Jul 27 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 3.63 | 7,937 | 28,811 | 2,479,685 | 2.5 M to 2.5 M (-0.32 %) |
Jul 27 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 3.84 | 12,460 | 47,846 | 2,487,622 | 2.5 M to 2.5 M (-0.50 %) |
Jul 25 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 4.11 | 700 | 2,877 | 2,500,082 | 2.5 M to 2.5 M (-0.03 %) |
Jul 25 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 4.25 | 30,600 | 130,050 | 2,500,782 | 2.5 M to 2.5 M (-1.21 %) |
Jul 18 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 4.71 | 12,500 | 58,875 | 2,531,382 | 2.5 M to 2.5 M (-0.49 %) |
Jul 18 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 5.15 | 300 | 1,545 | 2,543,882 | 2.5 M to 2.5 M (-0.01 %) |
Jul 10 2018 | ALRN | AILERON THERAPEUTI ... | Apple Tree Partners II - Annex ... | 10% Owner | Sell | J | 0.00 | 655,797 | 0 | 0 | 655.8 K to 0 (-100.00 %) |
Jul 10 2018 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Sell | J | 0.00 | 1,380,241 | 0 | 0 | 1.4 M to 0 (-100.00 %) |
Jun 26 2018 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Sell | S | 5.45 | 10,528 | 57,425 | 1,380,241 | 1.4 M to 1.4 M (-0.76 %) |
Jun 26 2018 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Sell | S | 5.86 | 913 | 5,353 | 1,390,769 | 1.4 M to 1.4 M (-0.07 %) |
Jun 26 2018 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Sell | S | 5.98 | 94,816 | 566,744 | 1,391,682 | 1.5 M to 1.4 M (-6.38 %) |
Jun 25 2018 | ALRN | AILERON THERAPEUTI ... | Morrison Jodie Pope | Director | Option Exercise | A | 6.02 | 10,000 | 60,200 | 10,000 | |
Jun 25 2018 | ALRN | AILERON THERAPEUTI ... | Shanafelt Armen | Director | Option Exercise | A | 6.02 | 10,000 | 60,200 | 10,000 | |
Jun 25 2018 | ALRN | AILERON THERAPEUTI ... | Bailey Jeffrey Allen | Director | Option Exercise | A | 6.02 | 10,000 | 60,200 | 10,000 | |
Jun 25 2018 | ALRN | AILERON THERAPEUTI ... | Ambros Reinhard J. | Director | Option Exercise | A | 6.02 | 10,000 | 60,200 | 10,000 | |
Jun 25 2018 | ALRN | AILERON THERAPEUTI ... | Winder Caleb Maxfield | Director | Option Exercise | A | 6.02 | 10,000 | 60,200 | 10,000 | |
Jun 25 2018 | ALRN | AILERON THERAPEUTI ... | MCARTHUR JOHN H | Director | Option Exercise | A | 6.02 | 10,000 | 60,200 | 10,000 | |
Jun 21 2018 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Sell | S | 5.30 | 1,447 | 7,669 | 1,486,498 | 1.5 M to 1.5 M (-0.10 %) |
Jun 21 2018 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Sell | S | 5.30 | 5,200 | 27,564 | 1,487,945 | 1.5 M to 1.5 M (-0.35 %) |
Jun 21 2018 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Sell | S | 5.30 | 1,447 | 7,669 | 1,486,498 | 1.5 M to 1.5 M (-0.10 %) |
Jun 21 2018 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Sell | S | 5.30 | 5,200 | 27,564 | 1,487,945 | 1.5 M to 1.5 M (-0.35 %) |
Jun 19 2018 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Sell | S | 5.30 | 139 | 737 | 1,493,145 | 1.5 M to 1.5 M (-0.01 %) |
Jun 19 2018 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Sell | S | 5.35 | 1,432 | 7,661 | 1,493,284 | 1.5 M to 1.5 M (-0.10 %) |
Jun 19 2018 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Sell | S | 5.32 | 7,961 | 42,345 | 1,494,716 | 1.5 M to 1.5 M (-0.53 %) |
Jun 14 2018 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Sell | S | 5.40 | 10,843 | 58,558 | 1,502,677 | 1.5 M to 1.5 M (-0.72 %) |
Jun 12 2018 | ALRN | AILERON THERAPEUTI ... | Dougherty Donald | SVP & Chief Financi ... | Buy | P | 5.40 | 3,000 | 16,200 | 5,000 | 2 K to 5 K (+150.00 %) |
Jun 11 2018 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Sell | S | 5.41 | 18,525 | 100,242 | 1,513,520 | 1.5 M to 1.5 M (-1.21 %) |
Jun 11 2018 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Sell | S | 5.40 | 9,617 | 51,963 | 1,532,045 | 1.5 M to 1.5 M (-0.62 %) |
Jun 11 2018 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Sell | S | 5.48 | 20 | 110 | 1,541,662 | 1.5 M to 1.5 M (0.00 %) |
Jun 08 2018 | ALRN | AILERON THERAPEUTI ... | Aivado Manuel | See Remarks | Buy | P | 5.61 | 1,000 | 5,610 | 1,000 | 0 to 1,000 |
Jun 04 2018 | ALRN | AILERON THERAPEUTI ... | Dougherty Donald | SVP & Chief Financi ... | Buy | P | 5.24 | 2,000 | 10,480 | 2,000 | 0 to 2 K |
May 17 2018 | ALRN | AILERON THERAPEUTI ... | LONGENECKER JOHN P PHD | President and CEO | Option Exercise | A | 5.50 | 30,000 | 165,000 | 30,000 | |
Apr 19 2018 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Sell | S | 6.29 | 104,799 | 659,500 | 1,541,682 | 1.6 M to 1.5 M (-6.37 %) |
Apr 19 2018 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Sell | S | 7.05 | 3,105 | 21,890 | 1,646,481 | 1.6 M to 1.6 M (-0.19 %) |
Mar 19 2018 | ALRN | AILERON THERAPEUTI ... | Bailey Jeffrey Allen | Director | Option Exercise | A | 9.02 | 20,000 | 180,400 | 20,000 | |
Jan 11 2018 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Sell | S | 9.80 | 150,000 | 1,470,435 | 1,649,586 | 1.8 M to 1.6 M (-8.34 %) |
Sep 28 2017 | ALRN | AILERON THERAPEUTI ... | Ambros Reinhard J. | Director | Option Exercise | A | 12.09 | 20,000 | 241,800 | 20,000 | |
Jul 27 2017 | ALRN | AILERON THERAPEUTI ... | Nelson Kira | See Remarks | Option Exercise | A | 13.00 | 36,844 | 478,972 | 36,844 | |
Jul 27 2017 | ALRN | AILERON THERAPEUTI ... | MCARTHUR JOHN H | Director | Option Exercise | A | 13.00 | 20,000 | 260,000 | 20,000 | |
Jul 27 2017 | ALRN | AILERON THERAPEUTI ... | Aivado Manuel | See Remarks | Option Exercise | A | 13.00 | 57,388 | 746,044 | 57,388 | |
Jul 27 2017 | ALRN | AILERON THERAPEUTI ... | Yanchik Joseph A., III | See Remarks | Option Exercise | A | 13.00 | 157,449 | 2,046,837 | 157,449 | |
Jul 27 2017 | ALRN | AILERON THERAPEUTI ... | Dougherty Donald | SVP & Chief Financi ... | Option Exercise | A | 13.00 | 60,331 | 784,303 | 60,331 | |
Jul 27 2017 | ALRN | AILERON THERAPEUTI ... | Shanafelt Armen | Director | Option Exercise | A | 13.00 | 20,000 | 260,000 | 20,000 | |
Jul 27 2017 | ALRN | AILERON THERAPEUTI ... | Winder Caleb Maxfield | Director | Option Exercise | A | 13.00 | 20,000 | 260,000 | 20,000 | |
Jul 27 2017 | ALRN | AILERON THERAPEUTI ... | Kapnick Scott | Director | Option Exercise | A | 13.00 | 20,000 | 260,000 | 20,000 | |
Jul 27 2017 | ALRN | AILERON THERAPEUTI ... | Morrison Jodie Pope | Director | Option Exercise | A | 13.00 | 20,000 | 260,000 | 20,000 | |
Jul 27 2017 | ALRN | AILERON THERAPEUTI ... | Gallagher Brian M. Jr. | Director | Option Exercise | A | 13.00 | 20,000 | 260,000 | 20,000 | |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | Apple Tree Partners II - Annex ... | 10% Owner | Option Exercise | C | 0.00 | 3,026,920 | 0 | 0 | |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | Apple Tree Partners II - Annex ... | 10% Owner | Option Exercise | C | 0.00 | 3,489,740 | 0 | 0 | |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | Apple Tree Partners II - Annex ... | 10% Owner | Buy | C | 0.00 | 655,797 | 0 | 655,797 | 0 to 655.8 K |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Option Exercise | C | 0.00 | 6,781,770 | 0 | 0 | |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Option Exercise | C | 0.00 | 4,238,607 | 0 | 0 | |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Option Exercise | C | 0.00 | 2,967,025 | 0 | 0 | |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Option Exercise | C | 0.00 | 3,706,056 | 0 | 0 | |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Option Exercise | C | 0.00 | 615,384 | 0 | 0 | |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Option Exercise | C | 0.00 | 1,250,000 | 0 | 0 | |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Buy | C | 0.00 | 1,780,564 | 0 | 1,799,586 | 19 K to 1.8 M (+9,360.55 %) |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | APPLE TREE PARTNERS II LP | 10% Owner | Buy | C | 0.00 | 18,771 | 0 | 19,022 | 251 to 19 K (+7,478.49 %) |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | Shanafelt Armen | Director | Option Exercise | C | 0.00 | 1,443,972 | 0 | 0 | |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | Shanafelt Armen | Director | Option Exercise | C | 0.00 | 1,654,411 | 0 | 0 | |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | Shanafelt Armen | Director | Option Exercise | C | 0.00 | 1,907,373 | 0 | 0 | |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | Shanafelt Armen | Director | Option Exercise | C | 0.00 | 3,390,885 | 0 | 0 | |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | Shanafelt Armen | Director | Buy | P | 15.00 | 250,000 | 3,750,000 | 1,094,987 | 845 K to 1.1 M (+29.59 %) |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | Shanafelt Armen | Director | Buy | C | 0.00 | 844,987 | 0 | 844,987 | 0 to 845 K |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | LV Management Group, LLC | Option Exercise | C | 0.00 | 1,443,972 | 0 | 0 | ||
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | LV Management Group, LLC | Option Exercise | C | 0.00 | 1,654,411 | 0 | 0 | ||
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | LV Management Group, LLC | Option Exercise | C | 0.00 | 1,907,373 | 0 | 0 | ||
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | LV Management Group, LLC | Option Exercise | C | 0.00 | 3,390,885 | 0 | 0 | ||
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | LV Management Group, LLC | Buy | P | 15.00 | 250,000 | 3,750,000 | 1,094,987 | 845 K to 1.1 M (+29.59 %) | |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | LV Management Group, LLC | Buy | C | 0.00 | 844,987 | 0 | 844,987 | 0 to 845 K | |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | AJU IB Investment Co., Ltd. | 10% Owner | Option Exercise | C | 0.00 | 483,501 | 0 | 0 | |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | AJU IB Investment Co., Ltd. | 10% Owner | Option Exercise | C | 0.00 | 4,411,765 | 0 | 0 | |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | AJU IB Investment Co., Ltd. | 10% Owner | Buy | P | 15.00 | 24,929 | 373,935 | 517,558 | 492.6 K to 517.6 K (+5.06 %) |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | AJU IB Investment Co., Ltd. | 10% Owner | Buy | C | 0.00 | 48,656 | 0 | 492,629 | 444 K to 492.6 K (+10.96 %) |
Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | AJU IB Investment Co., Ltd. | 10% Owner | Buy | C | 0.00 | 443,973 | 0 | 443,973 | 0 to 444 K |
Jul 06 2017 | ALRN | AILERON THERAPEUTI ... | Gallagher Brian M. Jr. | Director | Option Exercise | C | 0.00 | 1,979,188 | 0 | 0 | |
Jul 06 2017 | ALRN | AILERON THERAPEUTI ... | Gallagher Brian M. Jr. | Director | Option Exercise | C | 0.00 | 1,276,389 | 0 | 0 | |
Jul 06 2017 | ALRN | AILERON THERAPEUTI ... | Gallagher Brian M. Jr. | Director | Option Exercise | C | 0.00 | 1,471,551 | 0 | 0 | |
Jul 06 2017 | ALRN | AILERON THERAPEUTI ... | Gallagher Brian M. Jr. | Director | Option Exercise | C | 0.00 | 6,781,770 | 0 | 0 | |
Jul 06 2017 | ALRN | AILERON THERAPEUTI ... | Gallagher Brian M. Jr. | Director | Buy | P | 15.00 | 273,333 | 4,099,995 | 1,431,519 | 1.2 M to 1.4 M (+23.60 %) |